270 related articles for article (PubMed ID: 12719580)
21. HIV-1 gp140 epitope recognition is influenced by immunoglobulin DH gene segment sequence.
Wang Y; Kapoor P; Parks R; Silva-Sanchez A; Alam SM; Verkoczy L; Liao HX; Zhuang Y; Burrows P; Levinson M; Elgavish A; Cui X; Haynes BF; Schroeder H
Immunogenetics; 2016 Feb; 68(2):145-55. PubMed ID: 26687685
[TBL] [Abstract][Full Text] [Related]
22. Two N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain.
Utachee P; Nakamura S; Isarangkura-Na-Ayuthaya P; Tokunaga K; Sawanpanyalert P; Ikuta K; Auwanit W; Kameoka M
J Virol; 2010 May; 84(9):4311-20. PubMed ID: 20164234
[TBL] [Abstract][Full Text] [Related]
23. Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.
Ingale J; Tran K; Kong L; Dey B; McKee K; Schief W; Kwong PD; Mascola JR; Wyatt RT
J Virol; 2014 Dec; 88(24):14002-16. PubMed ID: 25253346
[TBL] [Abstract][Full Text] [Related]
24. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.
Thompson J; Pope T; Tung JS; Chan C; Hollis G; Mark G; Johnson KS
J Mol Biol; 1996 Feb; 256(1):77-88. PubMed ID: 8609615
[TBL] [Abstract][Full Text] [Related]
25. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
[TBL] [Abstract][Full Text] [Related]
26. Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure.
Ditzel HJ; Binley JM; Moore JP; Sodroski J; Sullivan N; Sawyer LS; Hendry RM; Yang WP; Barbas CF; Burton DR
J Immunol; 1995 Jan; 154(2):893-906. PubMed ID: 7529290
[TBL] [Abstract][Full Text] [Related]
27. Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C.
Strokappe N; Szynol A; Aasa-Chapman M; Gorlani A; Forsman Quigley A; Hulsik DL; Chen L; Weiss R; de Haard H; Verrips T
PLoS One; 2012; 7(3):e33298. PubMed ID: 22438910
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes.
Dorgham K; Dogan I; Bitton N; Parizot C; Cardona V; Debré P; Hartley O; Gorochov G
AIDS Res Hum Retroviruses; 2005 Jan; 21(1):82-92. PubMed ID: 15665647
[TBL] [Abstract][Full Text] [Related]
29. Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.
Pantophlet R; Ollmann Saphire E; Poignard P; Parren PW; Wilson IA; Burton DR
J Virol; 2003 Jan; 77(1):642-58. PubMed ID: 12477867
[TBL] [Abstract][Full Text] [Related]
30. Thermodynamic signatures of the antigen binding site of mAb 447-52D targeting the third variable region of HIV-1 gp120.
Killikelly A; Zhang HT; Spurrier B; Williams C; Gorny MK; Zolla-Pazner S; Kong XP
Biochemistry; 2013 Sep; 52(36):6249-57. PubMed ID: 23944979
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of HIV-1 gp120 antibody response using isotype IgM and IgG phage display libraries from a long-term non-progressor HIV-1-infected individual.
Torán JL; Kremer L; Sánchez-Pulido L; de Alborán IM; del Real G; Llorente M; Valencia A; de Mon MA; Martínez-A C
Eur J Immunol; 1999 Sep; 29(9):2666-75. PubMed ID: 10508241
[TBL] [Abstract][Full Text] [Related]
32. Heavy chain-only IgG2b llama antibody effects near-pan HIV-1 neutralization by recognizing a CD4-induced epitope that includes elements of coreceptor- and CD4-binding sites.
Acharya P; Luongo TS; Georgiev IS; Matz J; Schmidt SD; Louder MK; Kessler P; Yang Y; McKee K; O'Dell S; Chen L; Baty D; Chames P; Martin L; Mascola JR; Kwong PD
J Virol; 2013 Sep; 87(18):10173-81. PubMed ID: 23843638
[TBL] [Abstract][Full Text] [Related]
33. Germlining of the HIV-1 broadly neutralizing antibody domain m36.
Chen W; Li W; Ying T; Wang Y; Feng Y; Dimitrov DS
Antiviral Res; 2015 Apr; 116():62-6. PubMed ID: 25676867
[TBL] [Abstract][Full Text] [Related]
34. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition.
Koch M; Pancera M; Kwong PD; Kolchinsky P; Grundner C; Wang L; Hendrickson WA; Sodroski J; Wyatt R
Virology; 2003 Sep; 313(2):387-400. PubMed ID: 12954207
[TBL] [Abstract][Full Text] [Related]
35. Functional implications of the binding mode of a human conformation-dependent V2 monoclonal antibody against HIV.
Spurrier B; Sampson J; Gorny MK; Zolla-Pazner S; Kong XP
J Virol; 2014 Apr; 88(8):4100-12. PubMed ID: 24478429
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
Qiao Y; Man L; Qiu Z; Yang L; Sun Y; He Y
Antiviral Res; 2016 Aug; 132():252-61. PubMed ID: 27387828
[TBL] [Abstract][Full Text] [Related]
37. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range.
Yang WP; Green K; Pinz-Sweeney S; Briones AT; Burton DR; Barbas CF
J Mol Biol; 1995 Dec; 254(3):392-403. PubMed ID: 7490758
[TBL] [Abstract][Full Text] [Related]
38. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.
Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS
Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472
[TBL] [Abstract][Full Text] [Related]
39. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
Zvi A; Feigelson DJ; Hayek Y; Anglister J
Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibody m18 paratope leading to dual receptor antagonism of HIV-1 gp120.
Gift SK; McFadden K; Zentner IJ; Rajagopal S; Zhang MY; Dimitrov DS; Chaiken IM
Biochemistry; 2011 Apr; 50(14):2769-79. PubMed ID: 21417283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
